Skip to content

CPRT

S&P 500
Favorable · 64/100

Copart

Industrials
Diversified Support Services
Earnings Sep 2 · after the close

$29.73

2.5%

Updated Today 11:30 AM ET

Report Card

CPRT at a glance — five pillars scored 0–100 from real filed financials.

Value
0
Growth
0
Profitability
0
Health
0
Dividends
0

Overall: Favorable · 64/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Price — Past Year

▼ Down 36.9% over the last 12 months

Price 50-day average 200-day averageDCF fair value ±15%Source: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$27.78B

P/E

17.15x

Forward P/E (est.)

16.17x

ROE

16.6%

Revenue Growth

1.1%

EPS Growth

6.1%

Profit Margin

33.5%

FCF Yield

2.5%

Debt / Equity

0x

ROIC

22.0%

Interest Coverage

83.87x

Current Ratio

7.61x

Dividend Yield

Implied Growth (rev. DCF)

4.4%

Rating Score

64/100

Business Overview
Research

Copart (CPRT) is a large-cap company in the Diversified Support Services industry, part of the Industrials sector of the S&P 500, with a market value around $27.78B.

In its latest reported year it generated about $4.65B in revenue and $1.55B in net profit.

Our model rates CPRT Favorable (64/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Economic Moat

Evidence of durable competitive advantage in the filed financials (9 years of history).

Wide moat signalsMoat evidence score: 90/100

The filed history looks like a business competitors struggle to attack: high and steady margins, revenue that grows through cycles, and strong returns on capital.

Operating margin level100/100

37.3% average over the last 3 years

Operating margin stability62/100

±3.1 pts around 36.6% across 9 years

Revenue durability100/100

grew in 8 of the last 8 year-over-year periods

Free-cash-flow consistency100/100

positive in 9 of 9 years

Return on invested capital85/100

22.0% latest fiscal year

A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CPRT's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CPRT trades near $29.73, below its 50-day average ($31.91) and 200-day average ($37.53). Price below both averages is a downtrend — momentum is against buyers for now.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 45 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.

Volatility — ATR. Average True Range is the typical daily move. CPRT's is $1.02 (~3.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month CPRT found buyers near $27.85 (support) and sellers near $31.76 (resistance); its 52-week range is $27.85–$50.11. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 1.1× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Revenue Growth
Research

4Y CAGR

14.6%

3/4 checks passedRevenue growingRevenue growth beats sector midpointEPS growingEPS growing faster than revenue

Revenue moved from $1.45B in 2017 to $4.65B in 2025, a 15.7% compound annual growth rate. The most recent year was roughly flat (1.1%) year over year. Slower, mature growth is common for established businesses.

Profitability
Research
4/4 checks passedProfitableNet margin above sector midpointROE above 12%ROIC above 10%

Gross Margin

45.5%

Operating Margin

36.5%

Net Margin

33.4%

ROE

16.6%

Copart keeps about 33.5% of each sales dollar as net profit, with a 45.5% gross margin and 36.5% operating margin. Return on equity is 16.6% and return on invested capital about 22.0%. Margins this wide usually signal pricing power or a cost advantage.

Debt Analysis
Research
4/4 checks passedDebt under 1× equityDebt under 2× equityInterest covered 3×+Short-term bills covered

Total Debt

$11.01M

Net Debt

-$2.10B

Net cash position

Net Debt / EBITDA

-1.24x

Debt / Equity

0x

Leverage: debt-to-equity is 0.0x, and operating profit covers interest about 83.9x, with a current ratio of 7.6x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $11.01M of total debt against $2.11B of cash.

Cash Flow Analysis
Research
3/3 checks passedPositive free cash flowFCF yield above 2%Market expects achievable growth (<8%)

Operating CF

$1.80B

Free Cash Flow

$1.23B

FCF Margin

26.5%

In the latest year Copart produced about $1.80B of operating cash flow and $1.23B of free cash flow after capital spending. That is a free-cash-flow yield of about 2.5% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Valuation Analysis
Research
3/4 checks passedPositive earnings (P/E meaningful)P/E below sector's upper bandForward P/E below trailing (earnings growing)Trading below DCF fair value

P/E

17.15x

P/S

6.14x

P/B

4.46x

EV / EBITDA

CPRT trades at 17.2x trailing earnings (about 16.2x on estimated forward earnings), 6.1x sales, and 4.5x book value. Reverse-engineering today's price implies the market expects roughly 4.4% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

$19.30

Current price

$29.73

-35% · Above fair-value estimate

Starting FCF (latest 10-K)

$1.23B

Growth, years 1–5

1.1%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$8.37B
PV of terminal value$9.50B
Estimated equity value$17.87B
Shares outstanding926M

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where CPRT sits versus its Industrials sector peers in the S&P 500.

TTM P/E
17.2xCheap
Forward P/E
16.2xCheap
P/S ratio
6.1xExpensive
Revenue growth
1.1%Weak
EPS growth
6.1%Average
Gross margin
45.5%Average
Net margin
33.5%Strong
ROE
16.6%Average

Bands show the middle half (25th–75th percentile) of the 144 Industrials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How CPRT stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.

In the Industrials sector (273 S&P 500 companies), CPRT ranks #13 of 273 by our overall rating. It trades at a discount versus the sector on earnings (17.2x P/E vs. 31.9x median) with a lower return on equity (16.6% vs. 18.1%) and slower revenue growth (1.1% vs. 6.0%).

P/E vs sector

17.2x

median 31.9x

ROE vs sector

16.6%

median 18.1%

Growth vs sector

1.1%

median 6.0%

Sector rank

#13

of 273 by rating

CompanyP/ERev Gr.Rating
CPRTThis stock17.2x1.1%Favorable· 64
LDOS16x2.3%Favorable· 58
CTAS41.3x8.7%Favorable· 61
OTIS18.4x3.3%Neutral· 54
CW52.7x12.2%Neutral· 53
RYAAY13x11.4%Strong· 72
JBHT41.3x0.6%Neutral· 43
DOV26x4.0%Neutral· 44
Industrials median31.9x6.0%22/100

Valuation vs. quality map

sector medianLDOSCTASOTISCWRYAAYJBHTDOVCPRTP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Industrials companies by sub-industry and size. Sector median is across all 273 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $29.73 today · expected CAGR -9%2%

Metric20262027202820292030
Revenue$4.79B$4.93B$5.08B$5.23B$5.39B
Net income$1.58B$1.63B$1.68B$1.73B$1.78B
EPS$1.69$1.74$1.79$1.85$1.90
Share price (low)$16.90$17.41$17.93$18.47$19.02
Share price (high)$28.73$29.59$30.48$31.40$32.34
CAGR (low–high)-43% / -3%-23% / -0%-16% / 1%-11% / 1%-9% / 2%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for CPRT:

  • High net margins (33.5%) point to pricing power or efficiency.
  • Strong return on equity (16.6%) shows capital is put to work well.
  • A conservative balance sheet (debt/equity 0.0x) lowers risk.
  • Our model's overall read is Favorable (64/100).
Bear Case

The case against CPRT:

  • Revenue growth is slow (1.1%), limiting the upside engine.
  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Growth risk — sluggish revenue (1.1%) leaves little margin for execution missteps.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the fundamentals screen favourably: Copart is a large-cap industrials business growing at a mature pace, with solid profitability, and a sound balance sheet. It trades at 17.2x earnings, which our model scores Favorable (64/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 21 Wall Street analysts covering CPRT recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 3.8 / 5 across 21 analysts
Strong Buy 5Buy 8Hold 7Sell 1Strong Sell 0

Latest SEC Filings

CPRT's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

In the Idea Lab

CPRT — frequently asked questions

Is CPRT a good stock to buy?

We don't give buy or sell advice. Our model rates Copart Favorable (64/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.

What is CPRT's rating on The Stocks School?

Copart currently scores 64/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.

How our ratings work
Where does CPRT's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Copart's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for CPRT calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this CPRT analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CPRT. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.